RELENZA Trademark

Trademark Overview

On Friday, July 16, 2004, a trademark application was filed for RELENZA with the United States Patent and Trademark Office. The USPTO has given the RELENZA trademark a serial number of 78452022. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, August 28, 2025. This trademark is owned by Glaxo Group Limited. The RELENZA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of influenza
relenza

General Information

Serial Number78452022
Word MarkRELENZA
Filing DateFriday, July 16, 2004
Status800 - REGISTERED AND RENEWED
Status DateThursday, August 28, 2025
Registration Number3049319
Registration DateTuesday, January 24, 2006
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2005

Trademark Statements

Certificate of Correction for RegistrationIn the statement, Column 1, line 1, through line 2, "GLAXO GROUP LIMITED (UNITED KINGDOM CORPORATION)" should be deleted, and "GLAXO GROUP LIMITED (UNITED KINGDOM PRIVATE COMPANY LIMITED BY SHARES)" should be inserted.
Goods and Servicespharmaceutical preparations and substances for the treatment of influenza

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 26, 2004
Primary Code005
First Use Anywhere DateTuesday, November 30, 1999
First Use In Commerce DateTuesday, November 30, 1999

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type77 - NOT AVAILABLE
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type77 - NOT AVAILABLE
AddressGreenford, Middlesex UB6 0NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type77 - NOT AVAILABLE
AddressGreenford, Middlesex UB6 0NN
GB

Trademark Events

Event DateEvent Description
Friday, February 18, 2005ASSIGNED TO EXAMINER
Monday, February 28, 2005ASSIGNED TO EXAMINER
Monday, July 26, 2004NEW APPLICATION ENTERED
Wednesday, July 6, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 6, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 15, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 22, 2005ASSIGNED TO LIE
Wednesday, October 12, 2005NOTICE OF PUBLICATION
Tuesday, March 15, 2005NON-FINAL ACTION WRITTEN
Tuesday, March 15, 2005NON-FINAL ACTION E-MAILED
Tuesday, July 19, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 2, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 24, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, February 2, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 1, 2005PUBLISHED FOR OPPOSITION
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 13, 2011TEAS SECTION 8 & 15 RECEIVED
Thursday, February 2, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 2, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 15, 2016TEAS SECTION 8 & 9 RECEIVED
Wednesday, March 23, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, March 23, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 22, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 23, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 24, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 21, 2025TEAS SECTION 8 & 9 RECEIVED
Monday, July 21, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sunday, July 20, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, July 20, 2025POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Tuesday, July 22, 2025POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Wednesday, August 27, 2025TEAS SECTION 7 REQUEST RECEIVED
Thursday, August 28, 2025CORRECTION UNDER SECTION 7 - PROCESSED
Thursday, August 28, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, August 28, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, August 29, 2025ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, August 28, 2025REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

Related Keywords

relenza influenza treatment substances preparations pharmaceutical